// App-Quantinova.ai

: Effect of Delayed Cell Infusion in Patients with Large B-Cell Lymphoma Treated with CAR T-Cell Therapy

Researchers

Presenter

  • Andrew Jallouk

Principal Investigators

  • Lei Feng

  • Mansoor Noorani

  • Kaberi Das

  • Raphael E Steiner

  • Loretta J. Nastoupil

  • Misha Hawkins

  • Ranjit Nair

  • Jason Westin

  • Luis Fayad

  • Dai Chihara

  • Luis Enrique Malpica Castillo

  • Swaminathan P. Iyer

  • Sairah Ahmed

  • Elizabeth J Shpall

  • Partow Kebriaei

  • Sattva S. Neelapu

  • Paolo Strati

Medical Centers

  • UT MD ANDERSON CANCER CENTER, Houston, TX

  • Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

  • UTMDACC, Houston

  • Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX

  • Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX

  • The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

  • Solid malignancies

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • Axicabtagene ciloleucel

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved